146803-42-1

Basic information

• Product Name: Carbamic acid, [(1S)-1-formyl-3-methylbutyl]-, 9H-fluoren-9-ylmethyl ester
• CAS NO: 146803-42-1
• Molecular Formula: C21H23NO3
• Molecular Weight: 337.419
• Mol File: 146803-42-1.mol
• Article Data: 27

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-1-formyl-3-methylbutyl]-, 9H-fluoren-9-ylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-1-formyl-3-methylbutyl]-, 9H-fluoren-9-ylmethyl ester(146803-42-1)
• EPA Substance Registry System: Carbamic acid, [(1S)-1-formyl-3-methylbutyl]-, 9H-fluoren-9-ylmethyl ester(146803-42-1)

Safety Data

• Hazardous Substances Data: 146803-42-1(Hazardous Substances Data)

Upstream product

• 125814-21-3 (S)-4-Isobutyl-2,5-dioxo-oxazolidine-3-carboxylic acid 9H-fluoren-9-ylmethyl ester 
• 35661-60-0 Fmoc-Leu-OH 
• 124007-48-3 2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic acid benzotriazol-1-yl ester 
• 160908-97-4 (9H-fluoren-9-yl)methyl (S)-(1-(methoxy(methyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate 
• 139551-83-0 (S)-(9H-fluoren-9-yl)methyl (1-hydroxy-4-methylpentan-2-yl)carbamate 
• 103321-59-1 N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-leucine, acid chloride 

Downstream Products

• 66556-73-8 N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe 
• 1447762-82-4 3-(3-((S)-2-acetylamino-4-methylpentylamino)phenyl)-2H-chromen-2-one 
• 1465132-20-0 C₆₇H₈₃N₇O₁₁ 
• 1447762-80-2 3-(3-((S)-2-amino-4-methylpentylamino)phenyl)-2H-chromen-2-one 
• 1447762-78-8 3-(3-((S)-2-amino-Ac-SEVN-4-methylpentylamino)phenyl)-2H-chromen-2-one 
• 1447194-71-9 benzyl (4S)-4-(N-fmoc)amino-6-methyl-3-oxoheptanoate 
• 1447194-90-2 C₃₂H₄₅N₅O₅S₂ 
• 1447194-86-6 C₄₇H₅₅N₅O₇S₂ 
• 1447195-14-3 C₁₇H₂₂N₂O₂S 
• 1447195-00-7 benzyl 4-[(1S)-1-(N-fmoc)amino-3-methylbutyl]-2-methyl-1,3-thiazole-5-carboxylate 
• 1447195-06-3 benzyl 4-[(1S)-1-(N-fmoc)amino-3-methylbutyl]-2-phenyl-1,3-thiazole-5-carboxylate 

Relevant articles and documents

A solid-phase approach to mouse melanocortin receptor agonists derived from a novel thioether cyclized peptidomimetic scaffold

The solid-phase synthesis of a novel thioether cyclized peptidomimetic scaffold, displaying functionality at the i to i + 3 positions, is reported. The thioether bridge is formed on-bead by an intramolecular reaction between a chloroacetylated reduced pep

Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor

Angiogenesis, formation of new blood vessels from the existing vascular network, is a hallmark of cancer cells that leads to tumor vascular proliferation and metastasis. This process is mediated through the binding interaction of VEGF-A with VEGF receptor

α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions

The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein-protein interactions (PPIs). Herein, we demonstrate that sulfono-γ-AApeptides can be rationally designed to mimic the p53 α-helix and inhibit p53-MDM2 PPIs. The best

Synthesis and biological activity of peptide α-ketoamide derivatives as proteasome inhibitors

Proteasome activity affects cell cycle progression as well as the immune response, and it is largely recognized as an attractive pharmacological target for potential therapies against several diseases. Herein we present the synthesis of a series of pseudo